# Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)

> **NCT07313241** · PHASE2 · RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 68 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Prostate Fossa Radiotherapy
- **RADIATION:** Pelvic nodal Radiotherapy
- **DRUG:** Androgen Deprivation Therapy (ADT)

## Key facts

- **NCT ID:** NCT07313241
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-14
- **Primary completion:** 2030-11-14
- **Final completion:** 2030-11-14
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07313241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07313241, "Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07313241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*